These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2999501)

  • 1. [Chickenpox prevention in patients at risk with a special immunoglobulin].
    Thomas E; Enders-Ruckle G; Geursen RG
    Klin Padiatr; 1985; 197(5):415-8. PubMed ID: 2999501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varicella-zoster immune globulin for the prevention of chickenpox.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Feb; 33(7):84-90, 95-100. PubMed ID: 6422250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of specific intravenous varicella-zoster immunoglobulins in the prevention of varicella in immunocompromised children: clinical and serological evaluation].
    Macchia P; Favre C; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1987 Oct; 39(20):813-20. PubMed ID: 2830480
    [No Abstract]   [Full Text] [Related]  

  • 5. Varicella in pediatric renal transplant recipients.
    Lynfield R; Herrin JT; Rubin RH
    Pediatrics; 1992 Aug; 90(2 Pt 1):216-20. PubMed ID: 1322522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of Varitect in the prevention of diseases in children caused by varicella-zoster viruses].
    Bartosová D; Wiedermannová D
    Cesk Pediatr; 1993 May; 48(5):275-7. PubMed ID: 8374966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Varicella zoster immunoglobulin. Prophylactic use in risk patients].
    Geursen RG
    ZFA (Stuttgart); 1983 Mar; 59(7):342-7. PubMed ID: 6303013
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus.
    Miller E; Cradock-Watson JE; Ridehalgh MK
    Lancet; 1989 Aug; 2(8659):371-3. PubMed ID: 2569560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of varicella in immunocompromised patients on unpredictable occurrence of the disease in a children's ward: vaccine-boostered immune whole blood transfusion (VIB) method.
    Hirao T
    Biken J; 1984 Sep; 27(2-3):137-41. PubMed ID: 6100052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary infection with varicella-zoster virus in risk groups].
    Jovanović J; Cvjetković D; Pobor M; Brkić S
    Med Pregl; 1998; 51(3-4):151-4. PubMed ID: 9611959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of varicella in immunocompromised children. Clinical and serological evaluation of specific anti-varicella-zoster immunoglobulins].
    Macchia P; Abadessa A; Nardi M; Consolini R; Conaldi PG; Bendinelli M
    Minerva Pediatr; 1984 Nov; 36(21):1053-7. PubMed ID: 6099463
    [No Abstract]   [Full Text] [Related]  

  • 15. VariZIG for prophylaxis after exposure to varicella.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):69-70. PubMed ID: 16977283
    [No Abstract]   [Full Text] [Related]  

  • 16. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
    McKendrick MW; Lau J; Alston S; Bremner J
    J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new preparation of specific anti-varicella-zoster immunoglobulin. Clinical evaluation in immunodepressed subjects].
    Miceli Sopo S; Pesaresi MA; Stabile A
    Minerva Pediatr; 1987 Apr; 39(8):317-9. PubMed ID: 3614159
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer factor for the prevention of varicella-zoster infection in childhood leukemia.
    Steele RW; Myers MG; Vincent MM
    N Engl J Med; 1980 Aug; 303(7):355-9. PubMed ID: 6248780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards evidence based medicine for paediatricians. How effective is varicella-zoster immunoglobulin (VZIG) in preventing chickenpox in neonates following perinatal exposure?
    Tebruegge M; Pantazidou A; Curtis N
    Arch Dis Child; 2009 Jul; 94(7):559-61. PubMed ID: 19542068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.